Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Metastatic Breast CancerMetastatic Ovarian CancerMetastatic Pancreatic CancerAdvanced Solid TumorMetastatic Liver CancerMetastatic Endometrial Cancer
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-09-18
- Lead Sponsor
- EtiraRx Australia Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT06533332
- Locations
- 🇦🇺
Macquarie University Health, Ryde, New South Wales, Australia
🇦🇺Icon Cancer Centre Adelaide, Adelaide, South Australia, Australia
🇦🇺The Kinghorn Cancer Center, Sydney, New South Wales, Australia
News
No news found